Recent News

• 05.20.2025 - 2025 RBC Capital Markets Global Healthcare Conference
• 05.15.2025 - Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
• 05.14.2025 - Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
• 04.28.2025 - Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development
• 04.03.2025 - Clinical Project Manager
• 04.03.2025 - VP, Head of Biometrics
• 03.26.2025 - Medical Director
• 03.26.2025 - Director of Clinical Data Management

Recent Filings

• 05.14.2025 - 8-K Current report
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.14.2025 - S-3 Registration statement under Securities Act of 1933
• 05.14.2025 - EX-99.1 EX-99.1
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.28.2025 - 8-K Current report
• 04.28.2025 - EX-99.1 EX-99.1